Avelumab, Cetuximab, and Palbociclib in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Condition:   Head and Neck Squamous Cell Carcinoma
Interventions:   Drug: Avelumab;   Drug: Palbociclib;   Drug: Cetuximab
Sponsors:   Kathryn Gold;   Pfizer
Not yet recruiting

https://ift.tt/2vbvDiR